View in EDS

Empagliflozin attenuates intestinal inflammation through suppression of nitric oxide synthesis and myeloperoxidase activity in in vitro and in vivo models of colitis.

Saved in:
Bibliographic Details
Title: Empagliflozin attenuates intestinal inflammation through suppression of nitric oxide synthesis and myeloperoxidase activity in in vitro and in vivo models of colitis.
Authors: Makaro, Adam1 (AUTHOR), Świerczyński, Mikołaj1 (AUTHOR), Pokora, Kacper1 (AUTHOR), Sarniak, Barbara1 (AUTHOR), Kordek, Radzisław2 (AUTHOR), Fichna, Jakub1 (AUTHOR), Salaga, Maciej1 (AUTHOR) salaga.maciej@gmail.com
Source: Inflammopharmacology. Feb2024, Vol. 32 Issue 1, p377-392. 16p.
Database: Academic Search Ultimate
Description
ISSN:09254692
DOI:10.1007/s10787-023-01227-8